A retrospective study assessing the rate of fascial closure during AWR between patients treated with and without preoperative botulinum toxin A (BTA) injection
Latest Information Update: 21 Sep 2021
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hernia
- Focus Therapeutic Use
- 21 Sep 2021 Primary endpoint (fascial closure, defined as a complete suture closure of the hernia defect) met according to the results published in the American Journal of Surgery
- 20 Sep 2021 New trial record
- 01 Sep 2021 Results published in the American Journal of Surgery